Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: A phase II trial of oral estramustine and oral etoposide
Dive into the research topics of 'Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: A phase II trial of oral estramustine and oral etoposide'. Together they form a unique fingerprint.